Memorial Sloan-Kettering Cancer Center, New York, committed $10...

Memorial Sloan-Kettering Cancer Center, New York, committed $10 million to Knightsbridge V and $15 million to Accel Partners VIII, both early stage venture capital funds, said Michael Gutnick, chief investment officer at the $2 billion endowment. Memorial also committed $10 million to Thomas H. Lee V and Welsh Carson IX, both large-cap buyout funds. Funding will come from a $300 million private equity program established by the endowment three years ago.